Evaluation the effect of licorice for treatment of coronavirus

Phase 2

Recruiting

• Conditions: Covid-19.; Covid-19 disease; U07.1

• Registration Number: IRCT20200404046933N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 May 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients diagnosed for coronavirus according to clinic such as fever, cough and mylagia
Patients diagnosed for coronavirus according to paraclinic such as lymphopenia and increase of CRP
Patients in the range of 18-65 years old

Exclusion Criteria

Sensitivity to licorice and it derivatives
Patients with hepato, renal or respiratory disorders
Patients who take cytotoxic or corticosteroid drugs
Nursing or pregnant women

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Time interval until clinical symptoms improve. Timepoint: 3 days, 1 week and 2 weeks after treatment. Method of measurement: Time of recovery.;Lymphopenia. Timepoint: 3 days, 1 week and 2 weeks after treatment. Method of measurement: Cell counter device.;CRP level. Timepoint: 3 days, 1 week and 2 weeks after treatment. Method of measurement: CRP kit.